The Board of Directors of Guizhou Sanli Pharmaceutical Co.,Ltd has authorized a buyback plan on November 3, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.29 CNY | +0.08% |
|
-1.29% | -34.90% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.90% | 690M | |
+55.35% | 848B | |
+31.64% | 627B | |
-0.10% | 363B | |
+15.47% | 318B | |
+13.10% | 299B | |
+15.51% | 243B | |
+16.72% | 225B | |
+16.54% | 179B | |
+4.31% | 167B |
- Stock Market
- Equities
- 603439 Stock
- News GuiZhou SanLi Pharmaceutical Co.,Ltd
- Guizhou Sanli Pharmaceutical Co.,Ltd authorizes a Buyback Plan.